• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MDM2-ARF复合物调节p53的SUMO化修饰。

MDM2-ARF complex regulates p53 sumoylation.

作者信息

Chen Lihong, Chen Jiandong

机构信息

Molecular Oncology Program, H Lee Moffitt Comprehensive Cancer Center and Research Institute, 12902 Magnolia Drive, Tampa, FL 33612, USA.

出版信息

Oncogene. 2003 Aug 14;22(34):5348-57. doi: 10.1038/sj.onc.1206851.

DOI:10.1038/sj.onc.1206851
PMID:12917636
Abstract

The p53 tumor suppressor is regulated by MDM2-mediated ubiquitination and degradation. Ubiquitination of p53 is regulated by ARF, which binds to MDM2 and inhibits its E3 ligase function. P53 is also subjected to modification by conjugation of SUMO-1. We found that a p53 mutant deficient for MDM2 binding (p53(14Q19S)) is poorly sumoylated in vivo compared to wild-type p53. Overexpression of MDM2 increases the level of p53 sumoylation, which is further stimulated by expression of ARF. Stimulation of p53 sumoylation requires a highly conserved region (102-116) encoded by exon 2 of ARF and correlates with the ability of ARF to target p53 to the nucleolus. An MDM2 deletion mutant (MDM2(Delta222-437)) with activated cryptic nucleolar localization signal also targets p53 to the nucleolus and efficiently promotes p53 sumoylation in the absence of ARF. Direct targeting of p53 to the nucleolus enhances its sumoylation in an MDM2- and ARF-dependent fashion. These results show that p53 sumoylation is regulated by MDM2- and ARF-mediated nucleolar targeting.

摘要

p53肿瘤抑制因子受MDM2介导的泛素化和降解作用调控。p53的泛素化受ARF调节,ARF与MDM2结合并抑制其E3连接酶功能。p53还会发生SUMO-1缀合修饰。我们发现,与野生型p53相比,一种缺乏MDM2结合能力的p53突变体(p53(14Q19S))在体内的SUMO化水平较低。MDM2的过表达会增加p53的SUMO化水平,ARF的表达会进一步刺激这种增加。p53 SUMO化的刺激需要ARF外显子2编码的一个高度保守区域(102 - 116),并且与ARF将p53靶向核仁的能力相关。一种具有激活的隐匿性核仁定位信号的MDM2缺失突变体(MDM2(Delta222 - 437))也能将p53靶向核仁,并在没有ARF的情况下有效促进p53的SUMO化。将p53直接靶向核仁以MDM2和ARF依赖的方式增强其SUMO化。这些结果表明,p53的SUMO化受MDM2和ARF介导的核仁靶向作用调控。

相似文献

1
MDM2-ARF complex regulates p53 sumoylation.MDM2-ARF复合物调节p53的SUMO化修饰。
Oncogene. 2003 Aug 14;22(34):5348-57. doi: 10.1038/sj.onc.1206851.
2
Nucleolar Arf sequesters Mdm2 and activates p53.核仁中的Arf隔离Mdm2并激活p53。
Nat Cell Biol. 1999 May;1(1):20-6. doi: 10.1038/8991.
3
Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53.人类ARF外显子2中的突变破坏了其核仁定位,并损害了其阻止MDM2和p53核输出的能力。
Mol Cell. 1999 May;3(5):579-91. doi: 10.1016/s1097-2765(00)80351-2.
4
Sumoylation induced by the Arf tumor suppressor: a p53-independent function.由Arf肿瘤抑制因子诱导的类泛素化修饰:一种不依赖p53的功能
Proc Natl Acad Sci U S A. 2005 May 24;102(21):7689-94. doi: 10.1073/pnas.0502978102. Epub 2005 May 16.
5
Cooperative signals governing ARF-mdm2 interaction and nucleolar localization of the complex.调控ARF-mdm2相互作用及该复合物核仁定位的协同信号。
Mol Cell Biol. 2000 Apr;20(7):2517-28. doi: 10.1128/MCB.20.7.2517-2528.2000.
6
ARF function does not require p53 stabilization or Mdm2 relocalization.急性肾衰竭的功能不需要p53稳定或Mdm2重新定位。
Mol Cell Biol. 2002 Jan;22(1):196-206. doi: 10.1128/MCB.22.1.196-206.2002.
7
Stabilization of p53 by p14ARF without relocation of MDM2 to the nucleolus.p14ARF对p53的稳定作用,而不伴有MDM2重新定位于核仁。
Nat Cell Biol. 2001 May;3(5):445-52. doi: 10.1038/35074506.
8
PML regulates p53 stability by sequestering Mdm2 to the nucleolus.早幼粒细胞白血病蛋白通过将小鼠双微体2蛋白隔离在核仁中来调节p53的稳定性。
Nat Cell Biol. 2004 Jul;6(7):665-72. doi: 10.1038/ncb1147. Epub 2004 Jun 13.
9
Contribution of two independent MDM2-binding domains in p14(ARF) to p53 stabilization.p14(ARF)中两个独立的MDM2结合结构域对p53稳定性的作用。
Curr Biol. 2000 May 4;10(9):539-42. doi: 10.1016/s0960-9822(00)00472-3.
10
MDM2 promotes ubiquitination and degradation of MDMX.MDM2促进MDMX的泛素化和降解。
Mol Cell Biol. 2003 Aug;23(15):5113-21. doi: 10.1128/MCB.23.15.5113-5121.2003.

引用本文的文献

1
SUMOylation of the lysine-less tumor suppressor p14ARF counters ubiquitylation-dependent degradation.无赖氨酸肿瘤抑制因子p14ARF的类泛素化修饰可对抗泛素化依赖性降解。
Cell Death Dis. 2025 Jul 12;16(1):519. doi: 10.1038/s41419-025-07854-z.
2
The Nucleolus: A Central Hub for Ribosome Biogenesis and Cellular Regulatory Signals.核仁:核糖体生物发生和细胞调节信号的中心枢纽
Int J Mol Sci. 2025 Apr 28;26(9):4174. doi: 10.3390/ijms26094174.
3
Expanding Roles of the E2F-RB-p53 Pathway in Tumor Suppression.E2F-RB-p53通路在肿瘤抑制中的作用扩展
Biology (Basel). 2023 Dec 11;12(12):1511. doi: 10.3390/biology12121511.
4
The SUMOylation and ubiquitination crosstalk in cancer.癌症中的类泛素化修饰与泛素化修饰之间的相互作用
J Cancer Res Clin Oncol. 2023 Nov;149(17):16123-16146. doi: 10.1007/s00432-023-05310-z. Epub 2023 Aug 28.
5
New insights into cancer: MDM2 binds to the citrullinating enzyme PADI4.癌症研究新发现:MDM2 可与瓜氨酸化酶 PADI4 结合
Protein Sci. 2023 Aug;32(8):e4723. doi: 10.1002/pro.4723.
6
SUMOylation and NEDDylation in Primary and Metastatic Cancers to Bone.原发性和转移性骨癌中的小泛素样修饰和类泛素化修饰
Front Cell Dev Biol. 2022 Apr 6;10:889002. doi: 10.3389/fcell.2022.889002. eCollection 2022.
7
The Role of SUMO E3 Ligases in Signaling Pathway of Cancer Cells.SUMO E3连接酶在癌细胞信号通路中的作用
Int J Mol Sci. 2022 Mar 26;23(7):3639. doi: 10.3390/ijms23073639.
8
Nucleolar localization of the ErbB3 receptor as a new target in glioblastoma.核仁定位的 ErbB3 受体作为胶质母细胞瘤的一个新靶点。
BMC Mol Cell Biol. 2022 Mar 7;23(1):13. doi: 10.1186/s12860-022-00411-y.
9
p53 SUMOylation Mediates AOPP-Induced Endothelial Senescence and Apoptosis Evasion.p53 小泛素样修饰介导晚期氧化蛋白产物诱导的内皮细胞衰老和凋亡逃避。
Front Cardiovasc Med. 2022 Feb 3;8:795747. doi: 10.3389/fcvm.2021.795747. eCollection 2021.
10
It's Getting Complicated-A Fresh Look at p53-MDM2-ARF Triangle in Tumorigenesis and Cancer Therapy.情况愈发复杂——重新审视肿瘤发生与癌症治疗中的p53-MDM2-ARF三角关系
Front Cell Dev Biol. 2022 Jan 26;10:818744. doi: 10.3389/fcell.2022.818744. eCollection 2022.